If you’re treating an otherwise-fatal cancer, sure, although it would still great to further improve the treatment. If you’re treating a much less lethal autoi

If you’re treating an otherwise-fatal cancer, sure, although it would still great to further improve the treatment. If you’re treating a much less lethal autoimmune condition, then the calculation is a bit different.